|
Progesterone receptor (%)
|
|
Total plasma Apolipoprotein A1, mg/dL
|
0.41
|
(0.17, 0.65)
|
0.001
|
0.46
|
(0.22, 0.69)
|
<0.001
|
|
HDL Cholesterol, mg/dL
|
0.86
|
(0.41, 1.31)
|
<0.001
|
0.95
|
(0.51, 1.39)
|
<0.001
|
|
HDL Free Cholesterol, mg/dL
|
2.64
|
(1.03, 4.26)
|
0.002
|
2.88
|
(1.28, 4.48)
|
0.001
|
|
HDL Phospholipids, mg/dL
|
0.66
|
(0.31, 1.01)
|
<0.001
|
0.70
|
(0.36, 1.04)
|
<0.001
|
|
HDL Apolipoprotein A1, mg/dL
|
0.50
|
(0.22, 0.78)
|
0.001
|
0.56
|
(0.29, 0.83)
|
<0.001
|
|
HDL Apolipoprotein A2, mg/dL
|
1.16
|
(0.06, 2.26)
|
0.040
|
1.53
|
(0.48, 2.58)
|
0.005
|
|
HDL1 Phospholipids, mg/dL
|
1.02
|
(0.39, 1.64)
|
0.002
|
0.96
|
(0.35, 1.57)
|
0.003
|
|
HDL1Cholesterol, mg/dL
|
1.20
|
(0.43, 1.97)
|
0.003
|
1.15
|
(0.41, 1.89)
|
0.003
|
|
HDL1Free Cholesterol, mg/dL
|
3.36
|
(0.80, 5.92)
|
0.011
|
3.44
|
(0.95, 5.93)
|
0.008
|
|
HDL1 Apolipoprotein A1, mg/dL
|
0.81
|
(0.29, 1.34)
|
0.003
|
0.76
|
(0.25, 1.27)
|
0.004
|
|
HDL1 Apolipoprotein A2, mg/dL
|
6.75
|
(2.20, 11.3)
|
0.004
|
6.39
|
(2.08, 10.7)
|
0.004
|
|
HDL2 Phospholipids, mg/dL
|
2.54
|
(0.95, 4.13)
|
0.002
|
2.30
|
(0.61, 3.98)
|
0.008
|
|
HDL2 Cholesterol, mg/dL
|
3.87
|
(1.19, 6.54)
|
0.005
|
4.42
|
(1.70, 7.15)
|
0.002
|
|
HDL2 Free Cholesterol, mg/dL
|
10.9
|
(3.48, 18.4)
|
0.005
|
11.6
|
(4.39, 18.9)
|
0.002
|
|
HDL2 Apolipoprotein A2, mg/dL
|
6.01
|
(0.26, 11.8)
|
0.041
|
6.74
|
(1.26, 12.2)
|
0.017
|
|
HDL2 Apolipoprotein A1, mg/dL
|
2.15
|
(0.79, 3.51)
|
0.003
|
2.29
|
(0.95, 3.63)
|
0.001
|
|
HDL3 Phospholipids, mg/dL
|
2.53
|
(0.95, 4.11)
|
0.002
|
2.88
|
(1.32, 4.43)
|
0.001
|
|
HDL3 Cholesterol, mg/dL
|
3.75
|
(1.28, 6.22)
|
0.004
|
4.44
|
(1.94, 6.95)
|
0.001
|
|
HDL3 Free Cholesterol, mg/dL
|
11.48
|
(3.06, 19.9)
|
0.008
|
13.5
|
(5.05, 22.0)
|
0.002
|
|
HDL3 Apolipoprotein A1, mg/dL
|
2.04
|
(0.73, 3.34)
|
0.003
|
2.38
|
(1.09, 3.66)
|
0.001
|
|
VLDL4 Cholesterol, mg/dL
|
−3.59
|
(−6.88,−0.31)
|
0.033
|
−3.76
|
(−7.16,−0.37)
|
0.031
|
|
VLDL 4 Free Cholesterol, mg/dL
|
−7.59
|
(−14.9, −0.27)
|
0.043
|
−7.75
|
(−15.3,−0.20)
|
0.044
|
|
Ki 67, %
|
|
HDL Phospholipids, mg/dL
|
−0.25
|
(−0.47, −0.02)
|
0.033
|
−0.31
|
(−0.53,−0.08)
|
0.008
|
|
HDL1 Cholesterol, mg/dL
|
−0.48
|
(−0.96, −0.01)
|
0.048
|
−0.54
|
(−1.00,−0.07)
|
0.024
|
|
HDL1 Phospholipids, mg/dL
|
−0.40
|
(−0.80,−0.01)
|
0.043
|
−0.46
|
(−0.84,−0.08)
|
0.020
|
|
HDL1 Apolipoprotein A1, mg/dL
|
−0.31
|
(−0.64, 0.02)
|
0.066
|
−0.35
|
(−0.67,−0.03)
|
0.032
|
|
HDL1 Apolipoprotein A2, mg/dL
|
−3.23
|
(−6.01,−0.45)
|
0.024
|
−3.28
|
(−5.94,−0.62)
|
0.017
|
|
HDL2 Phospholipids, mg/dL
|
−1.08
|
(−2.06,−0.09)
|
0.033
|
−1.30
|
(−2.28,−0.31)
|
0.011
|
|
Nodal metastasis
|
|
VLDL1 Triglycerides, mg/dL
|
0.03
|
(0.00, 0.06)
|
0.033
|
0.03
|
(0.00, 0.07)
|
0.036
|
|
VLDL1 Free Cholesterol, mg/dL
|
0.38
|
(0.01, 0.74)
|
0.045
|
0.41
|
(−0.01, 0.83)
|
0.057
|
|
LDL2 Free Cholesterol, mg/dL
|
−0.19
|
(−0.38,−0.00)
|
0.049
|
−0.17
|
(−0.37, 0.02)
|
0.084
|
|
LDL3 Free Cholesterol, mg/dL
|
−0.21
|
(−0.40,−0.03)
|
0.026
|
−0.20
|
(−0.40,−0.01)
|
0.049
|
|
Estrogen receptor (%)
|
No significant associations
|
|
Grade 1–3
|
|
Tumor size, mm
|
